Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bicycle Therapeutics Plc ADR
(NQ:
BCYC
)
23.30
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Bicycle Therapeutics Plc ADR
< Previous
1
2
3
Next >
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
May 02, 2024
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
April 24, 2024
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics PLC (NASDAQ: BCYC) Making Surprising Moves in Friday Session
May 12, 2023
Via
Investor Brand Network
Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
March 05, 2024
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
February 28, 2024
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
February 20, 2024
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 07, 2024
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
December 14, 2023
From
Bicycle Therapeutics
Via
Business Wire
Bicycle Therapeutics to Host R&D Day on December 14
November 30, 2023
From
Bicycle Therapeutics
Via
Business Wire
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
November 02, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
October 30, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer
October 19, 2023
From
Bicycle Therapeutics
Via
Business Wire
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer
September 11, 2023
From
Bicycle Therapeutics
Via
Business Wire
Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 05, 2023
From
Bicycle Therapeutics
Via
Business Wire
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 03, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
July 18, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
July 12, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
July 12, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer
June 23, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in the TD Cowen Radiopharmaceutical Innovation Summit
June 13, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference
May 31, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics and Orano Med Present Preclinical Bicycle® Radio-Conjugate Data at TIDES 2023
May 11, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
May 10, 2023
From
Bayer
Via
Business Wire
Bicycle Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 04, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets
May 04, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Present at the 2023 AACR Annual Meeting
April 14, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Enhances Leadership Team with Key Appointments
April 03, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces a Strategic Collaboration with Novartis to Discover, Develop and Commercialize Bicycle® Radio-Conjugates
March 28, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
February 28, 2023
From
Bicycle Therapeutics
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.